Literature DB >> 21086761

Dopaminergic impact on cortical excitability in humans.

Michael A Nitsche1, Katia Monte-Silva, Min-Fang Kuo, Walter Paulus.   

Abstract

Dopamine is a major neuromodulatory agent of the central nervous system. The neurotransmitter has a non-linear dose-dependent effect on cortical excitability and activity, which depends on spontaneous activity, dopamine concentration, and dopaminergic sub-receptors, amongst others. By its impact on cortical and subcortical network activity and excitability, dopamine modulates such cognitive performance as attention, as well as learning and memory formation. Although animal studies have enhanced our knowledge about the physiology of dopamine considerably, the transferability of the results to conscious humans is limited due to altered spontaneous neuronal activity in anesthetized animals or slice experiments. Recently emerged noninvasive brain stimulation techniques enable the exploration of cortical excitability in humans. Here we review the respective experimental results and derive conclusions about how dopamine might affect the cortical excitability of the human brain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21086761     DOI: 10.1515/revneuro.2010.21.4.289

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  19 in total

1.  Possible association between DBH 19 bp insertion/deletion polymorphism and clinical symptoms in schizophrenia with tardive dyskinesia.

Authors:  Li Hui; Mei Han; Xu Feng Huang; Min Jie Ye; Ke Zheng; Jin Cai He; Meng Han Lv; Bao Hua Zhang; Jair C Soares; Xiang Yang Zhang
Journal:  J Neural Transm (Vienna)       Date:  2014-10-22       Impact factor: 3.575

2.  Speech dynamics are coded in the left motor cortex in fluent speakers but not in adults who stutter.

Authors:  Nicole E Neef; T N Linh Hoang; Andreas Neef; Walter Paulus; Martin Sommer
Journal:  Brain       Date:  2015-01-15       Impact factor: 13.501

3.  A causal role for the human subthalamic nucleus in non-selective cortico-motor inhibition.

Authors:  Jan R Wessel; Darcy A Diesburg; Nathan H Chalkley; Jeremy D W Greenlee
Journal:  Curr Biol       Date:  2022-07-15       Impact factor: 10.900

Review 4.  Modulating neural plasticity with non-invasive brain stimulation in schizophrenia.

Authors:  Alkomiet Hasan; Thomas Wobrock; Tarek Rajji; Berend Malchow; Zafiris J Daskalakis
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-09-24       Impact factor: 5.270

5.  Stronger tilt aftereffects in persons with schizophrenia.

Authors:  Katharine N Thakkar; Livon Ghermezi; Steven M Silverstein; Rachael Slate; Beier Yao; Eric D Achtyes; Jan W Brascamp
Journal:  J Abnorm Psychol       Date:  2020-12-10

6.  Differences in dopaminergic modulation to motor cortical plasticity between Parkinson's disease and multiple system atrophy.

Authors:  Shoji Kawashima; Yoshino Ueki; Tatsuya Mima; Hidenao Fukuyama; Kosei Ojika; Noriyuki Matsukawa
Journal:  PLoS One       Date:  2013-05-03       Impact factor: 3.240

7.  Pharmacological modulation of the short-lasting effects of antagonistic direct current-stimulation over the human motor cortex.

Authors:  Leila Chaieb; A Antal; D Terney; W Paulus
Journal:  Front Psychiatry       Date:  2012-07-05       Impact factor: 4.157

8.  EEG alterations during treatment with olanzapine.

Authors:  Detlef Degner; Michael A Nitsche; Frank Bias; Eckart Rüther; Udo Reulbach
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-03-23       Impact factor: 5.270

9.  Impairments of motor-cortex responses to unilateral and bilateral direct current stimulation in schizophrenia.

Authors:  Alkomiet Hasan; Theresa Bergener; Michael A Nitsche; Wolfgang Strube; Tilmann Bunse; Peter Falkai; Thomas Wobrock
Journal:  Front Psychiatry       Date:  2013-10-04       Impact factor: 4.157

10.  Dopamine, affordance and active inference.

Authors:  Karl J Friston; Tamara Shiner; Thomas FitzGerald; Joseph M Galea; Rick Adams; Harriet Brown; Raymond J Dolan; Rosalyn Moran; Klaas Enno Stephan; Sven Bestmann
Journal:  PLoS Comput Biol       Date:  2012-01-05       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.